DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
1/29/2009 6:38:27 AM
More...
|
DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
4/12/2007 10:35:28 AM
More...
|
DNA Therapeutics Announces Highly Significant Efficacy Against Xenografted Tumors In Animals Thanks To Its Molecule Dbait, In Association With Standard Radiotherapy
11/7/2006 10:12:25 AM
More...
|